HRP20192109T1 - Novi spoj i proces - Google Patents
Novi spoj i proces Download PDFInfo
- Publication number
- HRP20192109T1 HRP20192109T1 HRP20192109TT HRP20192109T HRP20192109T1 HR P20192109 T1 HRP20192109 T1 HR P20192109T1 HR P20192109T T HRP20192109T T HR P20192109TT HR P20192109 T HRP20192109 T HR P20192109T HR P20192109 T1 HRP20192109 T1 HR P20192109T1
- Authority
- HR
- Croatia
- Prior art keywords
- compound
- formula
- reaction
- process according
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1613054.4A GB201613054D0 (en) | 2016-07-28 | 2016-07-28 | New compound and process |
| PCT/GB2017/052190 WO2018020249A1 (en) | 2016-07-28 | 2017-07-27 | New compound and process |
| EP17748880.6A EP3490988B1 (en) | 2016-07-28 | 2017-07-27 | New compound and process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20192109T1 true HRP20192109T1 (hr) | 2020-02-21 |
Family
ID=56936838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20192109TT HRP20192109T1 (hr) | 2016-07-28 | 2017-07-27 | Novi spoj i proces |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10710998B2 (https=) |
| EP (1) | EP3490988B1 (https=) |
| JP (1) | JP6985367B2 (https=) |
| KR (1) | KR102396059B1 (https=) |
| CN (1) | CN109641891B (https=) |
| CY (1) | CY1122138T1 (https=) |
| DK (1) | DK3490988T3 (https=) |
| ES (1) | ES2751948T3 (https=) |
| GB (1) | GB201613054D0 (https=) |
| HR (1) | HRP20192109T1 (https=) |
| HU (1) | HUE046509T2 (https=) |
| LT (1) | LT3490988T (https=) |
| PL (1) | PL3490988T3 (https=) |
| PT (1) | PT3490988T (https=) |
| RS (1) | RS59566B1 (https=) |
| SI (1) | SI3490988T1 (https=) |
| SM (1) | SMT201900582T1 (https=) |
| TW (1) | TWI739871B (https=) |
| WO (1) | WO2018020249A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3142701T3 (en) | 2014-05-12 | 2018-08-13 | Verona Pharma Plc | New treatment |
| GB201502260D0 (en) | 2015-02-11 | 2015-04-01 | Verona Pharma Plc | Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound |
| PT4090654T (pt) * | 2020-01-17 | 2025-10-07 | Lupin Ltd | Métodos, processos e intermediários para a preparação de compostos de cromano |
| CN116917287A (zh) | 2021-04-29 | 2023-10-20 | 苏州盛迪亚生物医药有限公司 | 异喹啉酮类化合物及其用途 |
| JP2024545189A (ja) * | 2021-12-14 | 2024-12-05 | シーツァン ハイスコ ファーマスーティカル カンパニー リミテッド | 三環式縮合複素環系ｐｄｅ３／４二重阻害剤及びその用途 |
| GB202202297D0 (en) | 2022-02-21 | 2022-04-06 | Verona Pharma Plc | Formulation production process |
| EP4378942A1 (en) | 2022-12-02 | 2024-06-05 | Sandoz AG | Crystal form of a pde3/4 inhibitor |
| WO2025003643A1 (en) | 2023-06-26 | 2025-01-02 | Verona Pharma Plc | Particulate composition comprising ensifetrine |
| CN121620356A (zh) | 2023-06-26 | 2026-03-06 | 维罗纳制药公司 | 包含恩塞芬汀的颗粒组合物 |
| US20250073240A1 (en) | 2023-09-06 | 2025-03-06 | Verona Pharma Plc | New treatment |
| US20250249007A1 (en) | 2024-02-07 | 2025-08-07 | Verona Pharma Plc | Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease |
| WO2025168708A1 (en) | 2024-02-07 | 2025-08-14 | Verona Pharma Plc | Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease |
| WO2025176871A1 (en) | 2024-02-23 | 2025-08-28 | Inke, S.A. | Process for preparing pyrimido[6,1-a]isoquinoline-4-ones |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ185900A (en) | 1976-12-10 | 1981-04-24 | Hoechst Ag | Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines |
| FI64370C (fi) | 1977-05-05 | 1983-11-10 | Hoechst Ag | Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat |
| DE2847693A1 (de) | 1978-11-03 | 1980-05-22 | Hoechst Ag | Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen |
| DE3135831A1 (de) | 1981-09-10 | 1983-04-28 | Hoechst Ag, 6230 Frankfurt | 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| CA1237429A (en) | 1983-05-05 | 1988-05-31 | Frank Kienzle | Pyrimidone derivatives |
| ES2208310T3 (es) | 1999-03-31 | 2004-06-16 | Vernalis Limited | Derivados de pirimido(6,1-a) isoquinolin-4-ona. |
| PH12013500261A1 (en) | 2010-08-09 | 2013-03-04 | Verona Pharma Plc | Crystalline form of pyrimidio[6,1-a]isoquinolin-4-one compound |
| EP2968313B1 (en) | 2013-03-15 | 2018-01-31 | Verona Pharma PLC | Drug combination |
| DK3142701T3 (en) | 2014-05-12 | 2018-08-13 | Verona Pharma Plc | New treatment |
| CN110051627A (zh) | 2014-09-15 | 2019-07-26 | 维罗纳制药公司 | 包含rpl554的液体吸入制剂 |
| GB201502260D0 (en) | 2015-02-11 | 2015-04-01 | Verona Pharma Plc | Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound |
-
2016
- 2016-07-28 GB GBGB1613054.4A patent/GB201613054D0/en not_active Ceased
-
2017
- 2017-07-27 PT PT177488806T patent/PT3490988T/pt unknown
- 2017-07-27 WO PCT/GB2017/052190 patent/WO2018020249A1/en not_active Ceased
- 2017-07-27 HU HUE17748880A patent/HUE046509T2/hu unknown
- 2017-07-27 DK DK17748880T patent/DK3490988T3/da active
- 2017-07-27 TW TW106125312A patent/TWI739871B/zh active
- 2017-07-27 EP EP17748880.6A patent/EP3490988B1/en active Active
- 2017-07-27 LT LTEP17748880.6T patent/LT3490988T/lt unknown
- 2017-07-27 SI SI201730098T patent/SI3490988T1/sl unknown
- 2017-07-27 PL PL17748880T patent/PL3490988T3/pl unknown
- 2017-07-27 RS RS20191474A patent/RS59566B1/sr unknown
- 2017-07-27 US US16/309,435 patent/US10710998B2/en active Active
- 2017-07-27 SM SM20190582T patent/SMT201900582T1/it unknown
- 2017-07-27 ES ES17748880T patent/ES2751948T3/es active Active
- 2017-07-27 HR HRP20192109TT patent/HRP20192109T1/hr unknown
- 2017-07-27 CN CN201780046788.1A patent/CN109641891B/zh active Active
- 2017-07-27 JP JP2019503748A patent/JP6985367B2/ja active Active
- 2017-07-27 KR KR1020197004436A patent/KR102396059B1/ko active Active
-
2019
- 2019-10-04 CY CY20191101046T patent/CY1122138T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SMT201900582T1 (it) | 2019-11-13 |
| CY1122138T1 (el) | 2020-11-25 |
| JP2019527228A (ja) | 2019-09-26 |
| TWI739871B (zh) | 2021-09-21 |
| SI3490988T1 (sl) | 2019-11-29 |
| KR20190034231A (ko) | 2019-04-01 |
| PL3490988T3 (pl) | 2020-02-28 |
| EP3490988A1 (en) | 2019-06-05 |
| US10710998B2 (en) | 2020-07-14 |
| US20190330206A1 (en) | 2019-10-31 |
| HUE046509T2 (hu) | 2020-03-30 |
| JP6985367B2 (ja) | 2021-12-22 |
| DK3490988T3 (da) | 2019-10-28 |
| GB201613054D0 (en) | 2016-09-14 |
| KR102396059B1 (ko) | 2022-05-10 |
| WO2018020249A1 (en) | 2018-02-01 |
| RS59566B1 (sr) | 2019-12-31 |
| EP3490988B1 (en) | 2019-08-28 |
| LT3490988T (lt) | 2019-10-10 |
| PT3490988T (pt) | 2019-10-28 |
| CN109641891A (zh) | 2019-04-16 |
| ES2751948T3 (es) | 2020-04-02 |
| TW201806951A (zh) | 2018-03-01 |
| CN109641891B (zh) | 2021-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20192109T1 (hr) | Novi spoj i proces | |
| HRP20220750T1 (hr) | Postupak za proizvodnju spoja diariltiohidantoina | |
| JP2019527228A5 (https=) | ||
| HRP20200680T1 (hr) | Postupak proizvodnje n-[3-(aminometil)oksetan-3-il]karbamatnih međuprodukata | |
| HRP20211770T1 (hr) | 2-(morfolin-4-il)-1,7-naftiridini | |
| TR201902080T4 (tr) | N-asil-(3-sübstitüe)-(8-sübstitüe)-5,6-dihidro-[1,2,4]triazolo[4,3-a]pirazinlerinin yeni kiral sentezleri. | |
| RU2015143637A (ru) | Способы получения апоптоз агента | |
| CA2902624C (en) | Method for producing sulfonyl chloride compound | |
| HRP20191932T1 (hr) | Sinteza boronatnih soli i njihove uporabe | |
| CN106928117A (zh) | 一种氘代芳香类有机化合物的制备方法 | |
| PH12016502334A1 (en) | Method for producing fused heterocyclic compound | |
| RU2014137470A (ru) | Способы и соединения, которые можно использовать для синтеза антагонистов рецепторов орексина-2 | |
| PE20080109A1 (es) | N-sulfonilacion selectiva de alcoholes sustituidos con 2-aminotrifluoralquilo | |
| PH12018500582A1 (en) | Crosslinked nucleic acid guna, method for producing same, and intermediate compound | |
| CN104448898B (zh) | 一种派洛宁衍生物染料的合成方法 | |
| RU2012116208A (ru) | Способ получения n-ацилбифенилаланина | |
| CN103772278A (zh) | 一种重要四氢异喹啉衍生物中间体及其合成方法 | |
| HRP20171167T1 (hr) | Priprava intermedijera pirimidina koji služe za proizvodnju macitentana | |
| MX352470B (es) | Disales de acido malonico y metodo para preparar dihaluros de malonilo. | |
| HRP20170711T1 (hr) | Kontinuirani postupak za alkilaciju cikličnih tercijarnih amina | |
| ES2702193T3 (es) | Proceso para la preparación de compuestos de isoxazolina ópticamente activos | |
| NZ730843A (en) | Synthesis of copanlisib and its dihydrochloride salt | |
| PY1865684A (es) | Nuevos compuestos heterocíclicos como inhibidores de cdk8/19 | |
| RU2015129994A (ru) | Способ получения 1-(4-(4-(3, 4-дихлор-2-фторфениламино)-7-метоксихиназолин-6-илокси)пиперидин-1-ил)проп-2-ен-1-она | |
| CA3205579A1 (en) | Method for preparing an enantiomerically enriched form of 3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-a]pyrimidin-4-ium-5-olate |